Skip to content
MARKET
NIFTY 5023842.75+127.30+0.54%
SENSEX78553.20+418.45+0.54%
NIFTY BANK51236.80-89.15-0.17%
NIFTY IT33156.40+245.60+0.75%
NIFTY PHARMA19872.35+56.20+0.28%
NIFTY AUTO23145.90-112.40-0.48%
NIFTY FMCG56234.15+178.90+0.32%
INDIA VIX13.42-0.38-2.75%
NIFTY 5023842.75+127.30+0.54%
SENSEX78553.20+418.45+0.54%
NIFTY BANK51236.80-89.15-0.17%
NIFTY IT33156.40+245.60+0.75%
NIFTY PHARMA19872.35+56.20+0.28%
NIFTY AUTO23145.90-112.40-0.48%
NIFTY FMCG56234.15+178.90+0.32%
INDIA VIX13.42-0.38-2.75%
Barakfi
⌕/

Menu

⌂Home⌕Screener⊞Compare
TermsPrivacyDisclaimerShariah
Theme
Screener
WatchlistPortfolio
Log inGet started
⌂Home⌕Screener☆Watchlist▦Portfolio
Home/Screener/DVA
USHealthcareIndia
DVA logo

DaVita Inc.

Non-Compliant
₹146
1/6Pass

This stock doesn't meet 2 Shariah rules. See below to understand why.

53/100
Non-Compliant

This stock doesn't meet 2 Shariah rules. See below to understand why.

Market Cap₹9,732
Revenue₹13,643
Total Debt₹12,874
Debt / Mcap146.99%
Non-Halal Income4.28%
SectorHealthcare
✦
Healthcare›Healthcare
▲
Small Cap›Market cap of ₹9,732
⇅
Higher Risk›Debt ratio 146.99%
Ad
Price Chart
Loading chart...

Multi-Methodology Screening

Screened against 4 international Shariah standards

ConsensusNon-Compliant0/4 pass
S&P Shariah IndicesNon-Compliant
Debt Ratio147.0%/ 33.0%
Non-Halal Income4.3%/ 5.0%
Interest Income4.3%/ 5.0%
Receivables30.4%/ 33.0%
Cash & IB Securities4.0%/ 33.0%
SectorAllowed

Debt is 147.0% of 36m avg market cap, exceeding the 33% threshold set by S&P.

Debt is 132.3% of current market cap, exceeding the 33% threshold.

AAOIFI StandardsNon-Compliant
Debt Ratio73.7%/ 30.0%
Non-Halal Income4.3%/ 5.0%
Interest Income4.3%/ 5.0%
Receivables16.9%/ 49.0%
Cash & IB Securities4.0%/ 30.0%
SectorAllowed

Debt is 73.7% of total assets, exceeding the 30% threshold set by AAOIFI.

Debt is 73.7% of current total assets, exceeding the 30% threshold.

FTSE Yasaar (Maxis)Non-Compliant
Debt Ratio73.7%/ 33.0%
Non-Halal Income4.3%/ 5.0%
Interest Income4.3%/ 5.0%
Receivables16.9%/ 50.0%
Cash & IB Securities4.0%/ 33.0%
SectorAllowed

Debt is 73.7% of total assets, exceeding the 33% threshold set by FTSE.

Debt is 73.7% of current total assets, exceeding the 33% threshold.

Khatkhatay Independent NormsNon-Compliant
Debt Ratio73.7%/ 25.0%
Non-Halal Income4.3%/ 5.0%
Interest Income4.3%/ 5.0%
Receivables16.9%/ 100.0%
Cash & IB Securities4.0%/ 10.0%
SectorAllowed

Debt is 73.7% of total assets, exceeding the 25% threshold set by Independent.

Debt is 73.7% of current total assets, exceeding the 25% threshold.

Interest income is 4.3% of revenue, exceeding the 3% limit under Independent.

Each methodology uses different denominators and thresholds. A stock may be compliant under one standard but not another. The consensus reflects the majority verdict across all three.

Compliance check

Green = safe, amber = close to limit, red = over the limit

Debt level
146.99%
How much debt the company carriesLimit: 33.00%
Current debt
132.29%
Debt compared to current company valueLimit: 33.00%
Income purity
4.28%
How much income comes from non-halal sourcesLimit: 5.00%
Interest earned
4.28%

Similar stocks

Other stocks in Healthcare

LLY logo
LLYEli Lilly and Company
Cautious
₹936
₹8.4 L
JNJ logo
JNJJohnson & Johnson
Cautious
₹243
₹5.9 L
ABBV logo
ABBVAbbVie Inc.
Cautious
₹209
₹3.7 L
MRK logo
MRKMerck & Co., Inc.
Cautious
₹121
₹3.0 L
Interest income as portion of total revenueLimit: 5.00%
Money owed to company
30.41%
Outstanding receivables compared to company valueLimit: 33.00%
Cash & interest-bearing
4.01%
Cash and interest-bearing securities as a portion of total assetsLimit: 33.00%
Fixed Assets / Total Assets
29.81%
Asset composition indicatorNo hard threshold

Screening rules

Why it screened this way

✗

Debt is 147.0% of 36m avg market cap, exceeding the 33% threshold set by S&P.

✗

Debt is 132.3% of current market cap, exceeding the 33% threshold.

Screening results indicate whether this stock meets specific methodology criteria. They do not constitute a fatwa or religious ruling. Consult a qualified Shariah scholar for definitive guidance. View methodology